以质量求发展，以服务铸品牌

Journal of Nursing ›› 2021, Vol. 28 ›› Issue (6): 17-21.doi: 10.16460/j.issn1008-9969.2021.06.017

Previous Articles     Next Articles

  

  • Received:2020-08-19 Online:2021-03-25 Published:2021-04-08

PDF (PC)

352

Like

CLC Number: 

  • R473.74
[1] Benjamin EJ, Blaha MJ, Chiuve SE, et al.Heart Disease and Stroke Statistics-2017 Update:A Report from the American Heart Association[J].Circulation,2017, 135(10):e146-e603. DOI:10.1161/CIR.0000000000000485.
[2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018,51(9):666-682. DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
[3] Wardlaw JM, Murray V, Berge E, et al.Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke:An Updated Systematic Review and Meta-analysis[J].Lancet,2012,379(9834):2364-2372. DOI:10.1016/S0140-6736(12)60738-7.
[4] Chen YW, Sung SF,Chen CH, et al.Intravenous Thrombolysis Administration 3-4.5h after Acute Ischemic Stroke: A Retrospective, Multicenter Study[J].Front Neurol,2019,10:1038. DOI:10.3389/fneur.2019.01038.
[5] Powers WJ, Rabinstein AA, Ackerson T, et al.Guidelines forthe Early Management of Patients with Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J].Stroke, 2019,50(12):e344-e418. DOI:10.1161/STR.0000000000000211.
[6] Romano JG,Smith EE,Liang L,et al.Outcomes in Mild Acute Ischemic Stroke Treated with Intravenous Thrombolysis:A Retrospective Analysis of the Get with the Guidelines-stroke Registry[J].JAMA Neurol, 2015, 72(4):423-431. DOI:10.1001/jamaneurol.2014.4354.
[7] Saposnik G, Kapral MK, Liu Y, et al.iScore:A Risk Score to Predict Death Early after Hospitalization for an Acute Ischemic Stroke[J].Circulation, 2011, 123(7):739-749. DOI: 10.1161/CIRCULATIONAHA.110.983353.
[8] Saposnik G, Raptis S, Kapral MK, et al.The iScore Predicts Poor Functional Outcomes Early after Hospitalization for an Acute Ischemic Stroke[J].Stroke, 2011, 42(12):3421-3428. DOI:10.1161/STROKEAHA.111.623116.
[9] Saposnik G, Demchuk A, Tu JV,et al.The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J].J Stroke Cerebrovasc Dis,2013,22(6):876-882. DOI:10.1016/j.jstrokecerebrovasdis.2012.09.001.
[10] Park TH, Park SS,Ko Y,et al.The iScore Predicts Clinical Response to Tissue Plasminogen Activator in Korean Stroke Patients[J].J Stroke Cerebrovasc Dis, 2014,23(2):367-373. DOI:10.1016/j.jstrokecerebrovasdis.2013.05.025.
[11] Strbian D,Engelter S,Michel P,et al.Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score[J].Ann Neurol, 2012,71(5):634-641. DOI:10.1002/ana.23546.
[12] Al-Khaled M, Langner B, Brüning T.Predicting Risk of Symptomatic Intracerebral Hemorrhage and Mortality after Treatment with Recombinant Tissue-plasminogen Activator Using SEDAN Score[J].Acta Neurol Scand, 2016,133(4):239-244. DOI:10.1111/ane.12447.
[13] Flint AC, Cullen SP, Faigeles BS, et al.Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score[J].Am J Neuroradiol,2010,31(7):1192-1196. DOI:10.3174/ajnr.A2050.[14] Flint AC, Kamel H, Rao VA, et al.Validation of the Totaled Health Risks in Vascular Events (THRIVE) Score for Outcome Prediction in Endovascular Stroke Treatment[J].Int J Stroke,2014, 9(1):32-39. DOI10.1111/j.1747-4949.2012.00872.x.
[15] Flint AC, Faigeles BS, Cullen SP,et al.THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA[J].Stroke,2013,44(12):3365-3369. DOI:10.1161/STROKEAHA.113.002794.
[16] Flint AC, Gupta R, Smith WS, et al.The THRIVE Score Predicts Symptomatic Intracerebral Hemorrhage after Intravenous tPA Administration in SITS-MOST[J].Int J Stroke,2014,9(6):705-710. DOI:10.1111/ijs.12335.
[17] Mazya M, Egido JA, Ford GA, et al.Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated with Intravenous Alteplase: Safe Implementation of Treatments in Stroke(SITS) Symptomatic Intracerebral Hemorrhage Risk Score[J].Stroke,2012,43(6):1524-1531. DOI: 10.1161/STROKEAHA.111.644815.
[18] Nisar T, Hanumanthu R, Khandelwal P.Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models[J].J Stroke Cerebrovasc Dis,2019,28(11):104360. DOI:10.1016/j.jstrokecerebrovasdis.2019.104360.
[19] Cappellari M,Turcato G, Forlivesi S,et al.STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke[J].Stroke,2018,49(2):397-404. DOI:10.1161/STROKEAHA.117.018427.
[20] Diedler J, Ahmed N, Sykora M, et al.Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset[J].Stroke,2010,41(2):288-294. DOI:10.1161/STROKEAHA.109.559724.
[21] Cucchiara B, Kasner SE, Tanne D, et al.Factors Associated with Intracerebral Hemorrhage after Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials[J].Stroke, 2009,40(9):3067-3072. DOI:10.1161/STROKEAHA.109.554386.
[22] Ruecker M, Matosevic B, Willeit P, et al.Subtherapeutic Warfarin Therapy Entails an Increased Bleeding Risk after Stroke Thrombolysis[J].Neurology,2012,79(1):31-38. DOI: 10.1212/WNL.0b013e31825dcdf0.
[23] Miedema I, Luijckx GJ, De Keyser J, et al.Thrombolytic Therapy for Ischaemic Stroke in Patients Using Warfarin: A Systematic Review and Meta-analysis[J].J Neurol Neurosurg Psychiatry,2012, 83(5):537-540. DOI:10.1136/jnnp-2011-301794.
[24] Xian Y, Liang L, Smith EE, et al.Risks of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with IntravenousTissue Plasminogen Activator[J].JAMA,2012,307(24):2600-2608. DOI:10.1001/jama.2012.6756.
[25] Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al.Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score[J].J Stroke Cerebrovasc Dis,2017, 26(11):2622-2629. DOI:10.1016/j.jstrokecerebrovasdis.2017.06.030.
[26] Pan Y, Peng Y, Chen W,et al.THRIVE-c Score Predicts Clinical Outcomes in Chinese Patients after Thrombolysis[J].Brain Behav,2018,8(2):e00927. DOI:10.1002/brb3.927.
[27] Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation Following Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single Center Study[J].World Neurosurgery, 2017,101:155-160. DOI:10.1016/j.wneu.2017.01.091.
[28] 常红,赵洁,王晓娟,等.急性缺血性脑卒中患者静脉溶栓后出血预警模型的构建[J].中华护理杂志, 2019, 54(11):1648-1652. DOI:10.3761/j.issn.0254-1769.2019.11.010.
[29] Wang R, Zeng J, Wang F,et al.Risk Factors of Hemorrhagic Transformation after Intravenous Thrombolysis with rt-PA in Acute Cerebral Infarction[J].QJM, 2019,112(5):323-326. DOI:10.1093/qjmed/hcy292.
[1] CHEN En-lin, MO Feng-ling, ZHUANG Ze-ming, ZHANG Ming-zhe, ZHOU Jia-kun, HUANG Li-fang, JI Long-fei, ZHANG Li-fang. Assessment tools for unilateral spatial neglect after stroke: a scoping review [J]. Journal of Nursing, 2025, 32(3): 43-49.
[2] CHEN Jian, XIANG Li-jun, LUO Yan-si, CHEN Jian-hui, CUI Yan-li, LIAO Lin, YAN Ming-yu, ZHANG Xiao-mei. Construction of “Internet +” continuous rehabilitation management program for patients with post-stroke dysphagia [J]. Journal of Nursing, 2024, 31(24): 1-6.
[3] ZHOU Chun-xiang, RAO Yuan, CUI Meng-jiao, SHANG Zhi-ying, ZHANG Tian-lan, QIU Xi-chenhui, QIN Yan-ping. Application effect of sensor technology-based intelligent devices in gait rehabilitation of stroke patients: a Meta-analysis [J]. Journal of Nursing, 2024, 31(24): 44-50.
[4] LI Xiao-mei, TAO Ming, LI Qian-Qian, LI Lin-lin, LI Chun. Construction of symptom management theory-based self-management intervention scheme for neurogenic bladder patients [J]. Journal of Nursing, 2024, 31(22): 61-66.
[5] ZHANG Huang-xia, LI Zhuang-miao, LUO Wen-nan, LI Xiu-xia, HUANG Hui-xiang, LIN Ying-xin. Effect of sizi powder jiaozhen yuan-primary points application on hemiplegic shoulder pain in post-stroke patients [J]. Journal of Nursing, 2024, 31(20): 1-7.
[6] GOU Xin-yu, WU Jing, WEI Cui-cui, ZHAN Shui-rong, DU Pei-yun, WU Ai-rong. Influence of neurogenic bowel dysfunction on quality of survival in patients with spinal cord injury: a structural equation analysis [J]. Journal of Nursing, 2024, 31(20): 13-18.
[7] . [J]. Journal of Nursing, 2024, 31(20): 39-44.
[8] SHI Yang, GU Zhi-e, ZHU Tong, YU Jing, WANG Lin. Chain-mediated effects of social network and self-neglect between frailty and cognitive function in elderly patients with ischemic stroke [J]. Journal of Nursing, 2024, 31(17): 40-45.
[9] . [J]. Journal of Nursing, 2024, 31(14): 63-68.
[10] . [J]. Journal of Nursing, 2024, 31(12): 47-53.
[11] . [J]. Journal of Nursing, 2024, 31(10): 29-32.
[12] . [J]. Journal of Nursing, 2024, 31(10): 53-58.
[13] WEN Min, CHEN Bing, ZHOU Yong-ling, LIU Juan, ZHU Xiao-dan. Construction of joint intervention program of cognitive remediation based on mobile health APP for schizophrenia patients [J]. Journal of Nursing, 2024, 31(9): 1-4.
[14] . [J]. Journal of Nursing, 2024, 31(9): 15-19.
[15] LI Ding-ding, WANG Shuai-you, ZHU Shan-shan, GUO Xin, ZHANG Hui-min, WANG Hong-ru, PAN Qin. Supportive care needs assessment tools for stroke patients: a scoping review [J]. Journal of Nursing, 2024, 31(9): 48-53.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!